Background: In recent years, more and more evidence has demonstrated that a rare symptom, osteonecrosis of the jaw, may be associated with long-term use of bisphosphonates. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) adversely affects the quality of life, producing significant morbidity in afflicted patients. The most common signs and symptoms are swelling, exposed bone, local infection, pathologic fracture of the jaw, etc. Patients and methods: We report the case of an elderly female patient with alendronate-induced ONJ. After the patient discontinued taking bisphosphonates and her physician prescribed antiseptic mouthwashes and antibiotic drugs, her uncomfortable symptoms were relieved. Results: This side effect rarely occurs ...
BACKGROUND Osteoporosis affects millions of elderly patients. Bisphosphonates represent first-line ...
We describe a case of Osteonecrosis of the Jaw (ONJ) that developed in a 65-year-old Caucasian woman...
BACKGROUND: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of ...
SummaryBackgroundIn recent years, more and more evidence has demonstrated that a rare symptom, osteo...
AbstractBisphosphonate-associated osteonecrosis of the jaws (BRONJ) may have significant morbidities...
Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio ...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an adverse drug reaction described as the...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side effect of bisphosphonate t...
Background: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of oste...
Bisphonates are used widely to treat osteoporosis, hyperglycemia of malignancy, bone metastasis of s...
BACKGROUND: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of ost...
Bisphosphonates are potent inhibitors of osteoclast activity that reduce bone turnover and re-establ...
Although bisphosphonate-related osteonecrosis of the jaw (ONJ) develops mainly after tooth extractio...
We describe a case of Osteonecrosis of the Jaw (ONJ) that developed in a 65-year-old Caucasian woman...
Bisphosphonates are widely used in the management of metastatic disease to bone and in diseases of a...
BACKGROUND Osteoporosis affects millions of elderly patients. Bisphosphonates represent first-line ...
We describe a case of Osteonecrosis of the Jaw (ONJ) that developed in a 65-year-old Caucasian woman...
BACKGROUND: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of ...
SummaryBackgroundIn recent years, more and more evidence has demonstrated that a rare symptom, osteo...
AbstractBisphosphonate-associated osteonecrosis of the jaws (BRONJ) may have significant morbidities...
Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio ...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an adverse drug reaction described as the...
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side effect of bisphosphonate t...
Background: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of oste...
Bisphonates are used widely to treat osteoporosis, hyperglycemia of malignancy, bone metastasis of s...
BACKGROUND: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of ost...
Bisphosphonates are potent inhibitors of osteoclast activity that reduce bone turnover and re-establ...
Although bisphosphonate-related osteonecrosis of the jaw (ONJ) develops mainly after tooth extractio...
We describe a case of Osteonecrosis of the Jaw (ONJ) that developed in a 65-year-old Caucasian woman...
Bisphosphonates are widely used in the management of metastatic disease to bone and in diseases of a...
BACKGROUND Osteoporosis affects millions of elderly patients. Bisphosphonates represent first-line ...
We describe a case of Osteonecrosis of the Jaw (ONJ) that developed in a 65-year-old Caucasian woman...
BACKGROUND: Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of ...